Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis

AIMS: The specific TP receptor antagonist terutroban improves endothelial function after a single dose in patients with coronary artery disease. Our aim was to evaluate the effects and dose dependency of repeated-dose terutroban on endothelial function and platelet aggregation in high-cardiovascular...

Full description

Saved in:
Bibliographic Details
Main Authors: Lesault, Pierre-François, Boyer, Laurent, Pelle, Gabriel, Covali-Noroc, Ala, Rideau, Dominique, Akakpo, Servais, Teiger, Emmanuel, Dubois-Randé, Jean-Luc, Adnot, Serge
Format: Artigo
Language:Inglês
Published: Blackwell Science Inc 2011
Subjects:
Clinical Trials
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099371/
https://ncbi.nlm.nih.gov/pubmed/21564160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03858.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items